Ajanta Pharma Q3 net profit up 64 per cent to ₹177 cr

PTI New Delhi | Updated on February 02, 2021

Drug firm Ajanta Pharma on Tuesday reported a 64 per cent rise in its consolidated net profit to ₹177 crore for the quarter ended December mainly on account of robust sales.

The company had posted a net profit of ₹108 crore for the corresponding period of the previous fiscal, Ajanta Pharma said in a BSE filing.

Consolidated revenue from operations of the company stood at ₹749 crore for the quarter under consideration. It was ₹651 crore for the same period a year ago, it added.

Shares of Ajanta Pharma closed at ₹1,746.15 apiece on the BSE, down 0.59 percent from its previous close.

Published on February 02, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor